Aussie Expert Suggests New Flu Vaccines Could Increase Danger
This article was originally published in PharmAsia News
An Australian professor suggests vaccines that protect people against new types of influenza may actually increase the danger for those not considered at high risk
You may also be interested in...
EU Business Round-Up: Stada Enters Germany Top-5, Dr Wolff Takes Vagisan To Poland, Fidia And Sanova Strike Nasal Spray Deals
Acquiring six brands from GSK has propelled Stada into Germany's OTC top-5; Dr. Wolff has secured distribution for its Vagisan women's health brand in Poland; and Sanova and Fidia have added innovative nasal sprays to their respective portfolios.
The European Medicines Agency commits to exploring real-world data as part of its new Regulatory Science Strategy to 2025.
Amgen’s burgeoning biosimilar presence continues to grow apace and now the company has eyes firmly on the US market for eculizumab after brokering a deal with originator Alexion. The biosimilars developer chose to settle on three of Alexion’s patents ahead of a trial later this year.